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Antiretroviral therapy has increased the survival of patients with HIV/AIDS, thus necessi-
tating  health promotion practice with immunization. Vaccines are critical components for
protecting people living with HIV/AIDS (PLWHA). The purpose of study was to analyze the
vaccination status of PLWHA in outpatient care in Fortaleza, Ceará, Brazil. Cross-sectional
study  performed from June 2014 to June 2015. The screening was done with patients in
antiretroviral therapy, 420 patients underwent screening, but only 99 met  the inclusion crite-
ria. Data were collected for interviews using forms to characterize sociodemographic, clinical
and  vaccination situations. Only 14 patients had complete vaccination schedules. The most
used vaccines were hepatitis B, inﬂuenza vaccine and 23-valent pneumococcal. There was
no  difference between men and women regarding the proportion of PLWHA with full vac-
cination schedule or between sex, skin color, marital status, sexual orientation, religion or
occupational status. There was no difference between having or not having a complete vac-
cination schedule and age, years of education, family income or number of hospitalizations.
CD4+ T-cells count of patients with incomplete immunization was lower than patients with
complete immunization. Health education strategies can be done individually or in groups to
explain the importance of vaccination and to remind about doses to be administered. Most
patients did not have proper adherence to vaccination schedules, especially due to lack of
guidance. Results implied that education in health is important for vaccination adhesion,knowledge of adverse events and continuation of schemes.
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Introduction
More  than three decades after the recognition of acquired
immunodeﬁciency syndrome (AIDS), the pandemic of human
immunodeﬁciency virus (HIV) infection has had changes in its
characteristics.1,2 There was a reduction in the number of new
infections and deaths by HIV/AIDS at the global level, due to
the signiﬁcant progress in preventing the spread of infection
and an increase in the number of people who have access to
antiretroviral therapy (ART).3
ART has increased the survival of people living with
HIV/AIDS (PLWHA) leading to a chronic disease characteris-
tic, and it is considered that health promotion practices have
become of great importance for these patients who require
specialized care to maintain their quality of life. A health
promotion practice that may be considered is immunization.
PLWHA should weigh the beneﬁts and risks of vaccines, by
analyzing the viral load and CD4+ T-cells count, because vac-
cines have an important role as they can protect against
opportunistic diseases.4
Vaccines are critical components for protecting HIV-
infected adults from an increasing number of preventable
diseases. However, missed opportunities for vaccination
among PLWHA persist, likely due to concerns regarding the
safety and efﬁcacy of vaccines, as well as the changing nature
of vaccine guidelines.5
The National Immunization Program (NIP) of the Ministry
of Health of Brazil provides free vaccines to children, adoles-
cents, adults and seniors. PLWHA use the same standardized
vaccination schedule for adults, with adjustment according
to the type of vaccine. Regarding vaccines produced from
non-living microorganisms, the Ministry of Health of Brazil
recommends the following vaccines: diphtheria and tetanus
(adult double), hepatitis A, hepatitis B, inﬂuenza, pneumo-
coccal 23-valent and anti-rabies. For yellow fever vaccine,
individualize the risk/beneﬁt as the patient’s immune sta-
tus and the epidemiological situation in the region and, in
the event of exposure, vaccinate when CD4+ T-cells count
>200 cells/mm3. The rabies vaccine is only administered in
possible cases of exposure to the virus, when there is injury by
animals. In addition, before hepatitis B vaccination the result
of the anti-HBS exam must be observed.6
Several considerations justify conducting a study involv-
ing immunization of people with HIV/AIDS. The ﬁrst is that
prevention of infectious diseases is important when there is
impaired immunity because infection causes high morbidity
and mortality in these individuals. Although ART has provided
an increased survival rate of people with HIV, virus infection
is still a serious public health problem. This is a challenge in
many  ways, but above all the absence of an effective treatment
that leads to healing, beyond social and economic barriers that
interfere with adherence to treatment regimen.
Thus, the purpose of this study was to analyze the vac-
cination status of PLWHA in outpatient care, monitoring the
vaccination status, identifying the vaccination card of admin-
istered biopharmaceuticals to patients and the delay in doses,
the reasons why patients do not adhere to the prescribed vac-
cination schedules and to indicate educational strategies that
can be used in health promotion practices in the context of 1 6;2  0(5):487–493
PLWHA immunization. The results that may be obtained will
guide health promotion practices related to immunization of
people with HIV, and this may identify factors that prevent
vaccination, as well as to create a routine check of vaccina-
tion cards, to observe the doses of immunobiologicals already
administered and indicate the pending doses.
Methods
A cross-sectional descriptive study with quantitative
approach, developed in Brazil with PLWHA assisted in
outpatient care from June 2014 to June 2015 with screening of
all PLWHA on ART who attended the service.
Inclusion criteria were patients of both sexes; age greater
than or equal to 18; ART for at least three months; taking any
vaccine after knowledge of positive HIV serology; having a vac-
cination card to verify immunobiological administration and
signature of informed consent. Exclusion criteria consisted
of the presence of mental disease or any other condition
that would interfere with the individual’s participation in the
research. Other exclusion criteria were: expression of desire
to no longer participate in the study and follow-up loss.
Patients were invited to participate in the study when they
came to routine appointments at the clinic, which happens on
average of every three months. Those who agreed to partici-
pate formalized acceptance by signing the consent form and
underwent an interview lasting an average of half an hour in a
private environment. Two instruments were used in the inter-
view: Sociodemographic and Clinical Characterization Form
for People with HIV/AIDS and the Vaccination Situation of
People with HIV/AIDS Form. The researchers involved in the
project advised patients during the study to bring their vacci-
nation card to the clinic.
The Sociodemographic Characterization Form included the
variables: identiﬁcation, contact telephone number, address,
date of birth, sex, skin color, schooling (in years), marital sta-
tus, exposure category, sexual orientation, if they were living
with their partner, current partner’s HIV serology, number of
children, religion, occupational status, number of people liv-
ing in the same household, monthly income of the family,
HIV infection diagnosis time, previous/opportunistic diseases,
ART characteristics (usage time, antiretroviral drugs, dosage,
number of pills), number of hospitalizations by complications
of HIV infection, CD4+ T-cells count and viral load. This form
has already been validated and used in other studies involving
PLWHA.7–9
The Vaccination Situation of People with HIV/AIDS Form
was developed and validated speciﬁcally for this study. Before
being applied to the sample of the survey, a pilot test was
conducted with 20 PLWHA who did not compose the sam-
ple. It is a purely descriptive tool, aiming only to collect data
from patients’ vaccination card, since the vaccination card is
a document that must remain with the patient. It contains
the names of all vaccines recommended for PLWHA with a
checklist of the administered doses. From this, the vaccination
schedule was classiﬁed as complete or incomplete. In addi-
tion, there is space to put the reasons why a patient has not
taken the vaccine.
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Table 1 – Total vaccine doses for people living with
HIV/AIDS in outpatient care (N = 99).
Vaccines Total doses, N (%)
Non-living microorganism vaccine Diphtheria and tetanus
No doses registered 52 (52.6)
1st dose 16  (16.1)
1st and 2nd dose 5 (5.1)
1st, 2nd and 3rd dose 18 (18.1)
1st, 2nd and 3rd dose and reinforcement 8 (8.1)
Hepatitis B
No doses registered 22 (22.2)
1st dose 7 (7.1)
1st and 2nd dose 10 (10.1)
1st, 2nd and 3rd dose 60 (60.6)
Inﬂuenza
No doses registered 28 (28.2)
Single dose 71 (71.8)
23-valent pneumococcal
No doses registration 64 (64.7)
1st dose 35 (35.3)
Live and attenuated vaccines Measles and rubella
No doses registration 98 (98.9)
1st dose 1 (1.1)
Measles, mumps, and rubella (MMR)
No doses registered 83 (83.8)
1st dose 16 (16.2)
Yellow feverb r a z j i n f e c t d i s .
Quantitative variables (continuous and discrete) were ini-
ially analyzed by the Kolmogorov–Smirnov test to verify
he normality of distribution. For descriptive statistics, they
alculated the mean and standard deviation (SD) (paramet-
ic data) or the median, interquartile range and minimum
nd maximum values (nonparametric data). Comparisons
etween the strata related to participants with complete and
ncomplete immunization were made by using the t-test for
npaired variables (parametric data) or Mann–Whitney test
non-parametric variables).
For the nominal qualitative variables, descriptive statistics
nvolved the calculation of absolute and relative frequency.
he association between the independent variables (gender,
kin color, marital status, sexual orientation, religion, employ-
ent status) and the situation of the vaccine program was
ested by chi-square test or Fisher’s exact test (binary vari-
bles). A signiﬁcance level of 0.05 (5%) was established in
ll analyzes, and considered statistically signiﬁcant when p
alue was less than 0.05. The SPSS software version 19.0 for
indows (Statistical Package for Social Sciences, SPSS Inc.,
hicago, Illinois, USA, 2010) was used to perform the statistical
rocedures. The graphics were prepared using the GraphPad
RISM® software version 5.00 for Windows (GraphPad Soft-
are,  San Diego, CA, USA, 2007).
The project was submitted to the Ethics Committee of Fed-
ral University of Ceará and approved on 02.27.2014 under
rotocol No. 543745. All participants signed the informed
onsent. The secrecy of the participant’s identiﬁcation was
aintained and the research data was used only for scientiﬁc
urposes.
esults
ll PLWHA in ART that are attended at the clinic passed the
nitial screening, which recorded 420 patients. Only 99 had
heir vaccination card with their administered immunobiolog-
cal registered, as it was the hardest inclusion criteria to meet.
hen considering the 99 patients with vaccination cards, only
4 had a complete vaccination course record. Table 1 shows
he total number of vaccine doses administered to PLWHA.
onsidering the vaccine against diphtheria and tetanus, 52
eople (52.6%) had not taken at least one dose. As for a vac-
ine against hepatitis B, only 22 individuals (22.2%) did not
ave doses on record. Most of the PLWHA (71.8%) had taken
he annual dose of inﬂuenza vaccine. For the 23-valent pneu-
ococcal vaccine, only 35 patients had taken the ﬁrst dose.
ost individuals had not taken the double viral (measles and
ubella) (98.9%), measles, mumps, or rubella (MMR) (83.8%),
nd only seven PLWHA had record of a yellow fever vaccine
Table 1).
The high rates of vaccination against hepatitis B and
nﬂuenza occur because these two vaccines in Brazil are highly
ecommended for vulnerable populations such as the PLWHA.
hese two vaccines are offered free of charge to the population
uch as other vaccines recommended by the immunization
chedule in the country, but also annual campaigns against
nﬂuenza still occur.
Table 2 shows the associations between sociodemographic
ariables and the situation of complete and incompleteNo doses registered 92 (92.9)
1st dose 7 (7.1)
immunization. No statistically signiﬁcant differences were
found between men  and women regarding the proportion of
patients with complete vaccination schedule and between sex
(p = 0.220), skin color (p = 0.434), marital status (p = 0.573), sex-
ual orientation (p = 0.139), religion (p = 0.942) or occupational
status (p = 0.638), showing that for this sample, these variables
do not interfere with PLWHA following up at an outpatient
clinic to complete their immunization schedule (Table 2).
The comparative analysis of participants age was strati-
ﬁed according to the situation of the full vaccination schedule
(N = 14) and incomplete (N = 85). No statistically signiﬁcant
difference (p = 0.253) was found between the age of patients
with complete (mean ± SD: 42.8 ± 13.6 years) and incomplete
(mean ± SD: 39.4 ± 9.8 years) vaccination schedule. The t-
test for unpaired data was used to compare the two strata.
Regarding the number of years of study, there was also no
statistically signiﬁcant difference (p = 0.109) between the com-
plete (mean ± SD: 11.8 ± 5.2 years) and incomplete (mean ± SD:
14.2 ± 5.2 years) vaccination schedule.
The Mann–Whitney test was used for comparative analysis
of family income of stratiﬁed participants according to the sit-
uation of the vaccination schedule. There was no statistically
signiﬁcant difference (p = 0.376) between the family income
of the patients with complete immunization schedule (min-
imum, 25th percentile, median, 75th percentile, maximum:
US$ 40.00; 241.00; 466.00; 750.00; 8.333.00) and incomplete (US$
0.00; 320.00; 583.00; 833.00; 6.666.00).
The Mann–Whitney test was also applied for the number
of admissions of patients stratiﬁed according to the situation
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Table 2 – Association between the situation of complete
or incomplete immunization and sociodemographic
variables.
Sociodemographic
variables
Situation of vaccination schedule p valuea
Complete, N (%) Incomplete, N (%)
Sex
Male 7 (10.6%) 59 (89.4%) 0.220a
Female 7 (21.2%) 26 (78.8%)
Skin color
White 2 (6.9%) 27 (93.1%) 0.434b
Brown 8 (17.4%) 38 (82.6%)
Black 3 (23.1%) 10 (76.9%)
Another 1 (9.1) 10 (90.9%)
Marital status
Single 4 (11.1%) 32 (88.9%) 0.573b
Married 9 (18.4%) 40 (81.6%)
Separate 1 (12.5%) 7 (87.5%)
Widower 0 (0.0%) 6 (100.0%)
Sexual orientation
Heterosexual 12 (19.0%) 51 (81.0%) 0.139b
Homosexual 2 (8.7%) 21 (91.3%)
Bisexual 0 (0.0%) 13 (100.0%)
Religion
Catholic 9 (13.0%) 60 (87.0%) 0.942b
Protestant 3 (16.7%) 15 (83.3%)
Spiritualist 0 (0.0%) 1 (100.0%)
Other 0 (0.0%) 1 (100.0%)
Without
religion
2 (20.0%) 8 (80.0%)
Occupational status
Employee 7 (12.5%) 49 (87.5%) 0.638b
Unemployed 3 (11.5%) 23 (88.5%)
Retired 3 (30.0%) 7 (70.0%)
Removed 1 (16.7%) 6 (83.3%)
a Fisher’s exact test.
b Chi-square test.
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Fig. 1 – CD4+ T-cells count of participants stratiﬁed
according to the situation of vaccination schedule. T-test for
unpaired data was used to compare the two strata. CD4+
T-cells count of patients with incomplete immunization
(538.0 ± 240.9 cells/mm3) was lower (*p = 0.034) than
subjects with complete vaccination schedule
immunodeﬁciency should be delayed until satisfactory degree
of immune reconstruction with ART in order to improve theof the vaccination schedule, and no statistically signiﬁcant
difference (p = 0.462) was found for the complete vaccination
schedule (minimum, 25th percentile, median, percentile 75,
maximum: 0.0; 0.0; 0.0; 2.0; 3.0) and incomplete (0.0; 0.0; 0.0;
1.0; 4.0).
However, in the comparative analysis of the stratiﬁed
CD4+ T-cells count of participants in according to the situ-
ation of vaccination card using the t-test for unpaired data,
it was observed that the number of CD4+ T-cells count
observed in the patients with incomplete immunization
(538.0 ± 240.9 cells/mm3) was signiﬁcantly lower (p = 0.034)
that the observed in subjects with complete immunization
schedules (699.0 ± 354.6 cells/mm3) (Fig. 1).
The reasons for the 85 PLWHA not adhering to the pre-
scribed vaccination schedules were surveyed. Reasons for not
adhering to the prescribed vaccination schedule were: They
were not instructed as to the number of doses of vaccines
and schema (63.5%), do not know the beneﬁts of the vaccine
(16.5%), do not tolerate invasive procedures (injections) (8.2%),
have no time to seek health service that administers vaccines(699.0 ± 354.6 cells/mm3).
(7.1%), and have no ﬁnancial resources to attend the health
service (4.7%).
It should be emphasized the importance of the participa-
tion of all members of the multidisciplinary team in health
education process, which includes doctors, nurses, pharma-
cists, dietitians, physical therapists and other professionals
who care holistically the patient. The standardization of con-
duits during patient care is essential to a quality health care,
especially considering patients with low education and insuf-
ﬁcient income, which may hamper the access of individuals
to health services in general.
Discussion
Vaccination is important to improve immunity against oppor-
tunistic infections.10 For PLWHA, a vaccination schedule
involves vaccines produced from non-living microorganisms:
diphtheria and tetanus (three doses and booster every 10
years), hepatitis B (four doses, 0, 1, 2, 6 or 12 months), inﬂuenza
(annual), 23-valent pneumococcal (single and booster dose
after ﬁve years); and vaccines for live attenuated microorgan-
isms, which require analysis of CD4+ T-cells count and viral
load due to immunosuppression: measles, mumps and rubella
(one dose and may be monovalent, double or MMR)  and yellow
fever.4,10
For vaccines made from live microorganisms, the indi-
cation is based on CD4+ T-cells count (cells/mm3), and
a number greater than 350 (≥20%) indicates vaccines; for
between 200 and 350 (15-19%), it is necessary to evaluate
clinical and epidemiological risks for decision-making; less
than 200 (<15%), it is recommended that they do not vac-
cinate. Vaccination in symptomatic patients or with severevaccine response and reduce the risk of post-vaccination com-
plications. Vaccines produced from live microorganisms that
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re recommended: measles, mumps and rubella – they are not
ndicated for patients with severe immune deﬁciency; yellow
ever vaccine – has not been established as safe or effective in
eople with HIV, also CD4+ T-cells count (cells/mm3) and epi-
emiological risk situation should be observed; BCG – a second
ose of vaccine has been contraindicated since 2006, but is
ndicated for leprosy contacts after health assessment. Symp-
omatic or asymptomatic PLWHA with CD4+ T cells count less
han 200/mm3 must not be vaccinated.6
Studies about immunization of PLWHA are important,
owever, there is little Brazilian research on it. Research
hows a low prevalence of seroprotection against diphthe-
ia, poliomyelitis, tetanus and hepatitis B in migrants with
IV/AIDS that live in France and travel to their native
ountries, as they need to have their vaccine schedule
ompleted.11 Furthemore, fear of contamination and stigma-
ized social attitude are main impediments to dealing with
atients and providing services to them. It seems that creat-
ng effective knowledge about transmission and correcting the
ocio-cultural beliefs of health providers are key strategies to
ackle this problem.12
There was a great number of PLWHA without a vaccina-
ion card. This was demonstrated by the number of patients
ho  went through the screening, but were not included in the
tudy. These patients had no vaccination card, so in addition to
ot remembering exactly which vaccinations and doses have
een taken, they still did not have a record. The unavailabil-
ty of the vaccination card is a common ﬁnding, showing that
eople do not have the habit of keeping their vaccination cards
s a document.
The hepatitis B vaccine was administered to more  PLWHA.
esearch has shown that this vaccine is important for individ-
als with HIV/AIDS, for the prevention of liver diseases due to
nfection from the hepatitis B virus, and may also have pro-
nostic value in predicting the progression of HIV infection,
iven that it stimulates immune response.13,14 From 1999 to
011, there were 120,343 reported cases of hepatitis B in Brazil,
nd the rate increased from 0.3% in 1999 to 6.9% in 2010. Sex-
al contact is the predominant mean of transmission (52.7%).
LWHA are considered highly vulnerable to hepatitis B, and
or this reason, the vaccination is highly recommended for
his population. However, further studies are needed to esti-
ate the co-infection rate of HIV/hepatitis B in the Brazilian
opulation.15
For all people, including those living with HIV/AIDS, diph-
heria and tetanus after the full course of three doses may be
epeated every 10 years, as reinforcement.4 However, despite
his vaccine being available for free, few PLWHA had it
ecorded on their card.
Regarding the inﬂuenza vaccine, most people had taken
he single annual dose. In July, 2009, cases of sustained trans-
ission of inﬂuenza A (H1N1) were conﬁrmed in all regions
f Brazil. Many  patients presented pulmonary complications,
specially children, pregnant women, obese people and those
ith comorbidities, such as diabetes, hypertension, cardiovas-
ular disease, immunodeﬁciencies and malignancies. Thus,
he Brazilian Ministry of Health annually conducts inﬂuenza
accination campaigns in priority groups, including PLWHA,
hich explains the large number of doses administered in
his population.16 Inﬂuenza vaccination is shown as one of6;2 0(5):487–493 491
the most effective measures for prevention of severe inﬂuenza
and its complications. Currently in Brazil, vaccines contain
antigens against three inﬂuenza strains: A (H1N1), A (H3N2)
and B. These strains are chosen each year in order to pre-
vent disease caused by strains that will circulate the following
season.17 However, research is needed to estimate the co-
infection rate of PLWHA/inﬂuenza in Brazilian population.
PLWHA are more  likely to have severe and prolonged infec-
tions from the inﬂuenza virus. The use of ART has decreased
the rate of inﬂuenza complications in HIV-infected individ-
uals. As a result, treatment guidelines recommend an annual
inﬂuenza vaccination for all PLWHA.18,19
On the yellow fever vaccine, another study also showed the
unfamiliarity of PLWHA on vaccines. Although most partici-
pants adequately ascertain the vaccine as the main prevention
strategy against yellow fever, few were not aware of the sever-
ity and lack of speciﬁc treatment for yellow fever, so that
some patients have not taken the vaccine when indicated.20 To
assure maximum effectiveness yellow fever vaccine should be
given to HIV-infected patients after HIV replication has been
suppressed.21
The administration of live attenuated vaccines in patients
with immune deﬁciency should be subject to individual risk-
beneﬁt analysis and not be performed in cases of severe
immunosuppression.4 Perhaps this explains the fact that very
few patients had records of these biopharmaceuticals on their
vaccination cards. For the comparative analysis of CD4+ T-cells
count of the participants, it was observed that the number
of CD4+ T-cells count of the PLWHA with incomplete immu-
nization was signiﬁcantly lower than that observed in subjects
with a complete vaccination schedule. No articles were found
in the literature to observe this relationship. However, some
inferences can be made. The ﬁrst is that to have a complete
immunization schedule can demonstrate interest on the part
of PLWHA in maintaining good health practices, especially so
that this individual may have a greater concern with self-care.
The second inference is that because it seems closer to health
care, it is possible that these PLWHA with a full vaccination
schedule must also have adequate adherence to ART, which in
turn causes the CD4+ T-cells count to increase, the viral load
to decrease, and thus the immune system stays in proper con-
dition to receive biopharmaceuticals. It is noteworthy that all
selected patients for this study were using ART as this was one
of the inclusion criteria, also being a criterion for indication of
vaccines.
The use of ART protects PLWHA against diseases and
improves the immune response to vaccines, so the use of
ART is always observed, representing a security policy when
prescribing vaccines. It is noteworthy that vaccinations can
cause temporary changes in the viral load of HIV-1. Thus, rou-
tine tests should not coincide with vaccination and should be
made at least 30 days after receiving the vaccines.4,10,19
Most patients did not take vaccines because they are not
directed to do so by health professionals. Therefore, health
education strategies can be done individually or in a group
in order to explain the importance of vaccination for patients
and remind them about the doses to be administered. Health
education is an essential factor in the vaccination room for
those individuals to return to complete the dosing schedules.
However, health education is still something that is lacking
i s . 2 0
r
1
1
1492  b r a z j i n f e c t d 
due to overwhelming demand in the vaccine area, resulting in
an overload of work for professionals who work in it.
From the ﬁndings of this research, some strategies can
be recommended for health promotion in the context of the
immunization of PLWHA. The ﬁrst is to provide further guid-
ance about the number of vaccine doses and the importance
of completing the vaccination schedules in order to have ade-
quate immunization, as well as to promote the beneﬁts of the
vaccine, either through individual or group educational strate-
gies. The professional who prescribes vaccines for PLWHA
should also stay tuned to their speciﬁcations, through the
analysis of CD4+ T-cells count and viral load, so that all
patients can be awarded the beneﬁts of vaccination.
In this context, immunization is a strategy to promote
health and disease prevention, therefore advising on its ben-
eﬁts, indication, number of doses and adverse events is of
utmost importance for proper immunization of the entire
population. With the participation of members of the health
team, the immunization process of the population becomes
more effective and comprehensive, so the National Immu-
nization Program may effectively fulﬁll its role, being the
control, elimination and eradication of immunopreventable
diseases of interest in Brazilian and International Public
Health.
Regarding the limitations of the study, the main difﬁculty
was to ﬁnd PLWHA that possessed the vaccination card, which
interfered in the sample being completed. Despite wide dis-
semination of the study, many  patients showed no vaccination
card. They reported the card lost, forgotten or just did not have
it. A strategy that can be used in future studies regarding this
topic is to provide ﬁnancial assistance for patients to return
to the clinic to present their vaccination card, as PLWHA have
ﬁnancial difﬁculties.
Conclusion
To conclude, only a few PLWHA considered it important to
have their vaccination cards. Most did not properly adhere to
the prescribed vaccination schedules, primarily due to lack of
guidance on the subject, requiring health education to cover
these aspects. The evaluated sociodemographic variables did
not interfere in the patients fulﬁlling their vaccination sched-
ules. Thus, it emphasizes the importance of this work, as it
has identiﬁed deﬁcits related to the care of patients about
immunization and the health service on the guidelines of vac-
cines. Moreover, it was observed from the data analysis that
the CD4+ T-cells count was lower in patients with incom-
plete immunization, so the conclusion was that this could
be related to a deﬁcit in self-care or inadequate adherence
to ART.
For this reason, some procedures could have been per-
formed to conﬁrm this inference, such as the analysis of
self-care and adherence to ART through scales. As this was
not done in this work, it is suggested as a subject matter for
further research. Another aspect that could have helped would
be the existence of a computerized system at the study site, so
as to notify the vaccinated and unvaccinated PLWHA treated
at the outpatient service. This suggestion will be taken to the
1 1 6;2  0(5):487–493
hospital where the study was conducted, with a view of future
implementation in the service.
The study results implied that education in health is impor-
tant for adherence to vaccinations, knowledge of adverse
events and continuation of schemes, and that health profes-
sionals have essential action in this process, because they
accompany the patients. It emphasizing also the importance
of educational practices in the outpatient setting, especially
those that promote health, and thus guide PLWHA to be able
to self-care since there is still no cure for HIV/AIDS. Public poli-
cies exist and they are very clear regarding the vaccination of
PLWHA, however, health professionals need to do their role
of orientation of patients, demonstrating the importance of
vaccines for this population.
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